Range of qualified individuals: CDEC talked over the uncertainty in the number of sufferers with reasonably severe to significant hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some people who are classified as getting delicate or average disease might have a critical bleeding https://hemgenix40593.ttblogs.com/15769145/not-known-factual-statements-about-hemgenix